Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2137, doi. 10.1093/eurheartj/ehab295
- By:
- Publication type:
- Article
Works matching IS 0195668X AND DT 2021 AND VI 42 AND IP 22
Results: 17
1
2
Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease risk.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2152, doi. 10.1093/eurheartj/ehab261
- By:
- Publication type:
- Article
3
Suboptimal lipoprotein (a) control and residual plaque instability despite proprotein convertase subtilisin/kexin type 9 inhibitor use in heterozygous familial hypercholesterolaemia: insights from serial near-infrared spectroscopy imaging.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
4
Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2197, doi. 10.1093/eurheartj/ehab251
- By:
- Publication type:
- Article
5
The neutrophil–lymphocyte ratio: considerations for clinical application.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2216, doi. 10.1093/eurheartj/ehab166
- By:
- Publication type:
- Article
6
Neutrophil–lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2215, doi. 10.1093/eurheartj/ehab158
- By:
- Publication type:
- Article
7
Corrigendum to: CaMKII inhibition reduces electrical activation heterogeneities caused by mechanical stretch in the myocardium.
- Published in:
- 2021
- Publication type:
- Correction Notice
8
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2186, doi. 10.1093/eurheartj/ehab081
- By:
- Publication type:
- Article
9
Antiplatelet and direct oral anticoagulation management after coronary artery bypass graft surgery: the Cinderella of current cardiovascular trials, please show me (some) evidence.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2145, doi. 10.1093/eurheartj/ehab033
- By:
- Publication type:
- Article
10
Introduction to the Department of Cardiology in West China Hospital of Sichuan University.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2148, doi. 10.1093/eurheartj/ehab032
- By:
- Publication type:
- Article
11
Severe calcification of the Achilles' tendon.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
12
Security in BioMedical Research publications.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2141, doi. 10.1093/eurheartj/ehaa345
- By:
- Publication type:
- Article
13
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2154, doi. 10.1093/eurheartj/ehaa1080
- By:
- Publication type:
- Article
14
Aortic valve stenosis: the long and winding road.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2212, doi. 10.1093/eurheartj/ehaa1069
- By:
- Publication type:
- Article
15
Jennifer A. Doudna and Emmanuelle Charpentier.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2143, doi. 10.1093/eurheartj/ehaa1054
- By:
- Publication type:
- Article
16
Lipoproteins in chronic kidney disease: from bench to bedside.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2170, doi. 10.1093/eurheartj/ehaa1050
- By:
- Publication type:
- Article
17
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
- Published in:
- European Heart Journal, 2021, v. 42, n. 22, p. 2201, doi. 10.1093/eurheartj/ehaa1066
- By:
- Publication type:
- Article